Skip to content

H.R. 4434 · 119th Congress (2025–2027)

Cosmetic Supply Chain Transparency Act of 2025

This bill requires the Food and Drug Administration (FDA) to maintain a list of certain chemicals incidentally present in cosmetics, known as nonfunctional constituents, that are harmful to human health or the environment. The bill also imposes certain testing and disclosure requirements on cosmetics brand owners (i.e., entities bringing cosmetics to market) and suppliers of cosmetics, packaging, and ingredients.

For each listed nonfunctional constituent, the FDA must identify the ingredient or cosmetic in which the constituent is known or reasonably expected to be present. The FDA must also (1) accept petitions to add substances to the list, (2) issue guidance for industry related to testing and detecting such nonfunctional constituents, and (3) establish a committee to provide advice on creating the list and developing the required industry guidance.

Within a year of a nonfunctional constituent being added to the list, a supplier of an ingredient or cosmetic must test for that constituent and provide a brand owner the results and other information before selling the ingredient or cosmetic to the brand owner. A supplier of an ingredient or cosmetic must provide additional information about the item upon a brand owner's request.

Brand owners and other entities in the supply chain of a cosmetic must maintain records with information about the suppliers of ingredients and raw materials used in their cosmetics and provide such information to the FDA upon request.

The bill also imposes civil penalties for entities that violate this bill's provisions.

Show official title

To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.

Referred to committee

Latest actionReferred to committee

This bill’s path

This is H.R. 4434’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

Sponsor
Rep. Janice D. Schakowsky (D-IL-9)
Cosponsors
15 cosponsors

7 original · 8 later

15 D

  1. Rep. Debbie Dingell (D-MI-6)· Original · Jul 16, 2025
  2. Rep. Dwight Evans (D-PA-3)· Original · Jul 16, 2025
  3. Rep. Ro Khanna (D-CA-17)· Original · Jul 16, 2025
  4. Del. Eleanor Holmes Norton (D-DC)· Original · Jul 16, 2025
  5. Rep. Rashida Tlaib (D-MI-12)· Original · Jul 16, 2025
  6. Rep. Shri Thanedar (D-MI-13)· Original · Jul 16, 2025
  7. Rep. Bonnie Watson Coleman (D-NJ-12)· Original · Jul 16, 2025
  8. Rep. Sara Jacobs (D-CA-51)· Later · Jul 17, 2025
  9. Rep. Lloyd Doggett (D-TX-37)· Later · Jul 23, 2025
  10. Rep. Doris O. Matsui (D-CA-7)· Later · Aug 1, 2025
  11. Rep. Yvette D. Clarke (D-NY-9)· Later · Apr 21, 2026
  12. Rep. Lizzie Fletcher (D-TX-7)· Later · Apr 27, 2026
  13. Rep. Nydia M. Velázquez (D-NY-7)· Later · Jul 14, 2026
  14. Rep. Melanie A. Stansbury (D-NM-1)· Later · Sep 15, 2026
  15. Rep. Chellie Pingree (D-ME-1)· Later · Oct 1, 2026
Policy area
Health

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest

    Referred to committee

    Referred to the House Committee on Energy and Commerce.

    Sources

Committees

  1. HouseEnergy and CommerceReferred Jul 16, 2025

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Titles (2)
  1. Cosmetic Supply Chain Transparency Act of 2025

    Display title, Short title · Introduced in House

  2. To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.

    Official title · Introduced in House